Cyclis Pharmaceuticals
Cyclis Pharmaceuticals Inc. discovers and develops novel small molecule drugs for treatment of cancer
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Cyclis Pharmaceuticals Information
Cyclis Pharmaceuticals was acquired by
ArQule.
The acquisition happend on 2003-07-18.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Norwood
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$5M
Raised Total:$5M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2002 | Series A | 1 | $5M |
Ampersand Capital Partners Ampersand Capital Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
